What other stocks do shareholders of InSite Vision own?

Based on aggregate information from My MarketBeat watchlists, some companies that other InSite Vision investors own include Aralez Pharmaceuticals (ARLZ) , Novelion Therapeutics (NVLN) , Portola Pharmaceuticals (PTLA) and iBio (IBIO) .

How do I buy shares of InSite Vision?

Shares of INSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:INSV

InSite Vision (INSV) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free INSV Stock Alerts

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: 650,138 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get InSite Vision alerts:

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

About InSite Vision Stock (OTCMKTS:INSV)

InSite Vision Incorporated is an ophthalmic product development company that offers ophthalmic pharmaceutical products. The Company's portfolio of products is based on its DuraSite sustained drug delivery technology. The Company's offerings include BromSite and DexaSite. DuraSite sustained drug delivery technology is a synthetic polymer-based formulation to extend the residence time of a drug relative to conventional topical therapies. DuraSite enables topical delivery of a drug as a solution, gel or suspension and can be customized for delivering a variety of drug candidates. The Company is engaged in the research and development and commercial support with the DuraSite drug delivery technology for the following topical products: AzaSite, Besivance, BromSite, DexaSite, AzaSite Plus and ISV-101.

Ad Behind the Markets

The #1 Opportunity of the decade?

It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.

Click here to learn more >>>

INSV Stock News Headlines

April 19, 2024 | uk.finance.yahoo.com

Global Vision Care Market Projected to Surpass US$ 102 Billion by 2030 as Demand for Advanced Eye Care Solutions Grows

April 19, 2024 | forbes.com

From Concept To Impact: Navigating The Climate Tech Landscape With AI And Robotics

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

April 18, 2024 | markets.businessinsider.com

Autonomous Solutions, Inc. and VenHub Welcome Amazon Veteran Nader Kabbani to Its Board of Advisors

April 17, 2024 | msn.com

Conley’s Corner: A vision realized, but not yet complete for Timberwolves’ Mike Conley

April 17, 2024 | finance.yahoo.com

TELUS investing $135 million in Calgary

April 16, 2024 | finance.yahoo.com

DoorDash, Inc. (DASH) Interactive Stock Chart - Yahoo Finance

April 15, 2024 | msn.com

2024 "might be a turning point for Apple" — suppliers look elsewhere as Apple faces "frightening" question with no clear answer

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

April 14, 2024 | msn.com

AEW's Dustin Rhodes Looks Back On WWE Gimmick Goldust

April 13, 2024 | msn.com

Charlie Munger’s Critique of Tesla Sparks Reaction from Elon Musk: Agreement Amid Disappointment

April 11, 2024 | nytimes.com

‘Food, Inc. 2’ Review: A Second Course

April 10, 2024 | markets.businessinsider.com

Onum raises $28M to help businesses extract more value from their data at lower costs

April 10, 2024 | markets.businessinsider.com

JJ Watt Three-Time NFL Defensive Player of the Year & Walter Payton NFL Man of the Year Headlines 2024 U.S. Venture Open

April 6, 2024 | msn.com

Brain scans of Philly jazz musicians reveal secrets to reaching creative flow

April 5, 2024 | msn.com

Insight on safe eclipse viewing from local ophthalmologist

April 2, 2024 | msn.com

Iowa diver shares insight on dangers of underwater searches in light of Baltimore bridge collapse

April 2, 2024 | finance.yahoo.com

Brusco Vision Unveils Comprehensive Insight into LASIK for Farsightedness

March 4, 2024 | macrumors.com

Vision Pro Personas and EyeSight Improving With visionOS 1.1

February 18, 2024 | 9to5mac.com

Vision Pro

February 2, 2024 | macrumors.com

Apple Vision Pro Apps to Check Out

February 1, 2024 | msn.com

Apple's Vision Pro will launch with 600 new apps built just for the headset

February 1, 2024 | techcrunch.com

Apple Vision Pro to launch with over 600 apps and games optimized for the new headset

November 11, 2023 | msn.com

National Vision (EYE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

October 16, 2023 | benzinga.com

Insight Recognized as HashiCorp Focus Partner of the Year

September 18, 2023 | benzinga.com

BGL Announces the Sale of Insight Vision Group to Unifeye Vision Partners

September 14, 2023 | forbes.com

What Is Glaucoma? Types, Symptoms And Causes

See More Headlines

Receive INSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InSite Vision and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: OTCMKTS:INSV
CUSIP: N/A
CIK: 802724
Web: www.insitevision.com
Phone: +1-510-8658800
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

INSV Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of InSite Vision own?: Based on aggregate information from My MarketBeat watchlists, some companies that other InSite Vision investors own include Aralez Pharmaceuticals (ARLZ), Novelion Therapeutics (NVLN), Portola Pharmaceuticals (PTLA) and iBio (IBIO).
How do I buy shares of InSite Vision?: Shares of INSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INSV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

InSite Vision (INSV) Stock Price, News & Analysis

About InSite Vision Stock (OTCMKTS:INSV)

INSV Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

INSV Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info